A5083990234- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Breast Cancer Treatment Studies
- Endometrial and Cervical Cancer Treatments
- Advanced Radiotherapy Techniques
- Advances in Oncology and Radiotherapy
- Breast Lesions and Carcinomas
- Colorectal and Anal Carcinomas
- Cervical Cancer and HPV Research
- Global Cancer Incidence and Screening
- Management of metastatic bone disease
- Hormonal and reproductive studies
- Radiomics and Machine Learning in Medical Imaging
- Sarcoma Diagnosis and Treatment
- Bladder and Urothelial Cancer Treatments
- Cancer Treatment and Pharmacology
- Radiation Dose and Imaging
- Cancer survivorship and care
- Economic and Financial Impacts of Cancer
- Chemotherapy-induced cardiotoxicity and mitigation
- Ovarian cancer diagnosis and treatment
- Cancer Diagnosis and Treatment
- BRCA gene mutations in cancer
- Cardiac Imaging and Diagnostics
- Cancer, Lipids, and Metabolism
University of California, San Diego
2014-2023
University Medical Center
2023
University Hospital and Clinics
2023
University of Kansas Medical Center
2023
The University of Kansas Cancer Center
2023
UC San Diego Health System
2018-2021
University of California System
2019
University of California San Diego Medical Center
2018-2019
La Jolla Alcohol Research
2019
Moores Cancer Center
2018
Background African American (AA) men in the general US population are more than twice as likely to die of prostate cancer (PC) compared with non‐Hispanic white (NHW) men. The authors hypothesized that receiving care through Veterans Affairs (VA) health system, an equal‐access medical would attenuate this disparity. Methods A longitudinal, centralized database >20 million veterans was used assemble a cohort 60,035 (18,201 AA [30.3%] and 41,834 NHW [69.7%]) who were diagnosed PC between...
5α-Reductase inhibitors (5-ARIs), commonly used to treat benign prostatic hyperplasia, reduce serum prostate-specific antigen (PSA) concentrations by 50%. The association of 5-ARIs with detection prostate cancer in a PSA-screened population remains unclear.To test the hypothesis that prediagnostic 5-ARI use is associated delayed diagnosis, more advanced disease at and higher risk cancer-specific mortality all-cause than other or no PSA-decreasing drugs.This population-based cohort study...
Background Population‐based studies demonstrate that Black men in the United States have an increased risk of death from prostate cancer. Determinants racial disparities are multifactorial, including socioeconomic and biologic factors. Methods The authors conducted a pooled analysis patients derived 152 centers within Veterans Health Administration. cohort included who had nonmetastatic diagnosed between 2001 2015 received definitive radiation therapy. primary endpoint was cancer‐specific...
Our goal was to determine the impact of pathologic response after neoadjuvant chemotherapy in triple negative breast cancer (TNBC) on subsequent risk locoregional recurrence (LRR) and disease-free survival (DFS) setting adjuvant radiation therapy.This an institutional review board-approved retrospective chart patients with clinical stage I-III treated chemotherapy, local surgery (breast conservation or mastectomy), therapy between 1997 2015. Medical records were reviewed for stage, tumor...
Disparities in prostate cancer-specific mortality (PCSM) between African American and non-Hispanic White (White) patients have been attributed to biological systemic factors. We evaluated drivers of these disparities the Surveillance, Epidemiology, End Results (SEER) national registry an equal-access system, Veterans Health Administration (VHA).We identified diagnosed with cancer 2004 2015 SEER (n = 311 691) VHA 90 749). analyzed association race metastatic disease at presentation using...
Pleomorphic adenoma is the most common neoplasm arising in salivary glands. Surgical management primary therapeutic modality. With use of modern surgical techniques, recurrence infrequent, and facial nerve sparing norm. However, for patients with recurrent disease, risk further relapses increased resection alone, particularly those whom multiple recurrences have already occurred. The role adjuvant radiotherapy this setting remains uncertain. Although neutron superior to conventional...
Background: Undifferentiated pleomorphic sarcoma (UPS) of the maxillary sinus is an extremely rare malignancy head and neck. Surgery mainstay treatment for UPS; however, proximity to vital structures makes it challenging achieve negative surgical margins. Adjuvant therapy including radiation with or without chemotherapy generally indicated. Despite advances in multimodality treatment, objective response rates available therapies prognosis metastatic UPS remain dismal. Immunotherapy has...